RxDoctor Payments DataLook up a doctor →

Danielle Dehoratius, MD

Procedural Dermatology · Bryn Mawr, PANPI 1245346873

Payments from drug & device makers

$11,662in general payments, 2019–2025

Across 465 payments — averaging $25.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • AbbVie$2K
  • Biofrontera Inc.$2K
  • Galderma Laboratories, L.p.$680
  • Sun Pharmaceutical Industries Inc.$651
  • Novartis$620
  • plus $4K from 30 others

What the payments were for

  • Speaking & faculty fees$1,50013%
  • Food & beverage$9,96085%
  • Education$2022%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,662 in reported general payments places this provider in the 85th percentile of 26 procedural dermatology providers in Pennsylvania.

See all procedural dermatology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$363,763
Medicare patients
1,093
Services billed
5,585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab16$66,010
Fluorouracil69$3,838
Clobetasol Propionate64$2,198
Tacrolimus18$2,016
Betamethasone Dipropionate46$1,501
Ketoconazole91$1,376
ValacyclovirValacyclovir Hcl16$1,302
Imiquimod20$1,083
Hydroxychloroquine Sulfate20$1,005
Acitretin11$819
Metronidazole13$668
Fluconazole34$620
Nystatin52$570
Mupirocin48$521
Triamcinolone Acetonide40$392

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Bryn Mawr

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →